3rd Jul 2006 13:31
Premier Research Group03 July 2006 PREMIER RESEARCH GROUP Appointment of a Director Premier Research Group plc (AIM: PRG) ("Premier Research", "Company" or"Group"), the international pharmaceutical services group is today pleased toannounce the appointment of Dr John Gilly (48 years old) as an ExecutiveDirector of the Company. Prior to this appointment Dr Gilly has worked as a consultant for a number ofcompanies including; SAIC Frederick Inc providing management and scientificadvice on the US NCI/NIH program, Prezacor Inc providing project consulting foranalgesic device development, and Dermansonics Inc advising on an ultrasonicdelivery device project. Before joining Premier Research he has held the post ofVice President at Bioreliance Corporation and at ImClone Systems Incorporated. Dr Gilly has options over 200,000 ordinary shares of 1 pence each in the Company("Ordinary Shares"). This beneficial interest represents approximately 0.36 percent. of the Company's current issued share capital. This appointment became effective on 1 July 2006 and the contents of thisannouncement include the full disclosures required under Schedule 2, Para (g) ofthe AIM Rules. Premier Research Group plc Dr Simon Yaxley, Chief Executive Tel: 01344 458 311Bernard Gallagher, Chief Financial Officer Tel: 01344 458 309 Buchanan Communications Tel: 020 7466 5000Lisa Baderoon / Rebecca Skye Dietrich email:[email protected] Evolution SecuritiesSimon Leathers / Lloyd Thomas Tel: 020 7071 4300 Notes to editors: About Premier Research Premier Research is a growing contract research organisation (CRO) involved inthe design and execution of clinical trials (Phases II-IV) on behalf ofpharmaceutical and biotechnology companies. Premier is established in threetherapeutic areas - oncology, CNS (central nervous system) and anti-infectives -with a strong underlying expertise in paediatrics. Through a focused approach toclinical management, the company has built a reputation with its customers fordelivery of its services, and has demonstrated organic growth following itsrecent acquisitions. Premier has also established itself as an activeparticipant in the consolidation activity within the sector. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
PRG.L